| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |